Who writes these articles and what are the sources?

Each draft is written from the ESMO and NCCN guidelines, Turkish Society of Medical Oncology documents, peer-reviewed studies and regulatory approval documents; news sites and pharmaceutical promotional pages are not treated as sources. Nothing is published until Prof. Dr. H. Ibrahim Petekkaya has read and approved the text. When the evidence changes, the article is not quietly edited: a dated update paragraph is added at the top and the original publication date is kept.

Do these articles replace medical advice?

No. They set out what guidelines and peer-reviewed studies report, in language a patient can follow. A decision for one person is made only after the pathology report, the imaging and the stage have been seen, so discuss anything that seems to fit your situation with the doctor treating you.

How often are the articles updated?

Each article reflects what was known on its publication date. When a guideline changes or a new trial reports, a dated update paragraph is added at the top and the original date is kept, so a reader can see both when it was written and what has since changed.

Can I ask about my own report under an article?

Comments are closed on every article. Questions about your own pathology, imaging or genomic report go through the channels on the contact page, and documents are reviewed before the consultation. Patients who want an opinion on a plan made at another centre can use the second opinion process.

Which sources are used?

ESMO and NCCN guidelines, Turkish Society of Medical Oncology documents, peer-reviewed studies and regulatory documents from the EMA, the FDA and the Turkish Medicines and Medical Devices Agency are used. News sites, promotional pages and social media posts are not. Every article lists its sources with links.

Oncology Blog

This blog answers the questions patients ask most often in the consulting room, each with its source. It covers how long chemotherapy runs, how to read a genomic test report and what a guideline change actually alters. Articles are written and reviewed before publication by Prof. Dr. H. Ibrahim Petekkaya, medical oncologist in Izmir, Türkiye.